Chamindra Laverty

Home
About
Help/FAQs
Search Options
- UC Davis
- UCI
- UCLA
- UCSD
- UCSF
- All UC Health
- USC
- All
- Find People
- Find Everything

Title(s)	Clinical Professor, Neurosciences
School	Vc-health Sciences-schools
Address	9500 Gilman Drive # La Jolla CA 92093
vCard	Download vCard

Overview

webpage

Clinical Profile

Bibliographic

selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Prospective Study of Video Hand Opening Time as a Quantitative Measurement of Myotonia in Patients With Myotonic Dystrophy Type 1. Neurology. 2026 Apr 14; 106(7):e214747. Leeuwenberg KE, Sansone VA, Hamel J, Hung M, Dekdebrun JM, Lizio A, Eichinger K, Gagnon C, Roxburgh RH, Subramony SH, Statland JM, Elsheikh BH, Turner C, Matthews EL, Ragole TE, Sampson JB, Schoser B, Takahashi MP, Wicklund MP, Swenson AJ, Laverty CG, Shieh PB, Greene EP, Raymond J, DeSpain E, Thornton CA, Mul K, Johnson NE, Myotonic Dystrophy Clinical Research Network. PMID: 41747205.

View in: PubMed Mentions:
Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study. PLoS One. 2025; 20(12):e0331163. Mul K, Eichinger K, Hung M, Sansone VA, Gagnon C, Subramony S, Roxburgh RH, Hamel J, Statland JM, Elsheikh B, Turner C, Sampson J, Ragole T, Matthews E, Schoser B, Swenson A, Laverty C, Shieh P, Greene EP, Takahashi M, Wicklund M, Dekdebrun J, Raymond J, DeSpain E, Thornton CA, Johnson NE, Myotonic Dystrophy Clinical Research Network. PMID: 41379803; PMCID: PMC12697934.

View in: PubMed Mentions:
Onasemnogene abeparvovec gene therapy for treatment of patients with spinal muscular atrophy: Updated real-world practical considerations. J Neuromuscul Dis. 2025 Nov 10; 22143602251391258. Proud CM, Kichula EA, Matesanz SE, Kumar A, Saito K, Laverty CG, Farrar MA, Bharucha-Goebel DX, Haberlová J, Mundada V, Kwon JM, McMillan HJ. PMID: 41212681.

View in: PubMed Mentions: Fields:
Neu Neurology
Expert Consensus on Genetic Diagnostic Approaches for Patients With Limb-Girdle Muscular Dystrophy. Neurology. 2025 Nov 25; 105(10):e214291. Straub V, Clause AR, Donkervoort S, Kang PB, Laverty CG, Niu Z, Wicklund MP, Bönnemann CG, Cooper ST, Díaz-Manera J, Johnson NE, Narayanaswami P, Vissing J, Walter MC, Craige C, Weihl CC. PMID: 41151001; PMCID: PMC12570070.

View in: PubMed Mentions: Fields:
Neu Neurology
Translation:Humans
Danon disease in male patients: a prospective natural history study to augment understanding of the phenotype. Orphanet J Rare Dis. 2025 Oct 21; 20(1):530. Khedro T, Attias J, Eshraghian E, Tsotras M, Margolin E, Yassin S, Silver E, Bui Q, Borooah S, Laverty CG, Taylor MRG, Adler ED, Hong KN. PMID: 41121270; PMCID: PMC12542076.

View in: PubMed Mentions:
Long-Term Evaluation of Givinostat in Duchenne Muscular Dystrophy, and Natural History Comparisons. Ann Clin Transl Neurol. 2025 Nov; 12(11):2335-2348. McDonald CM, Guglieri M, Vucinic D, Acsadi G, Brandsema JF, Bruno C, Finanger EL, Harper A, Lobato ML, Masson R, Muelas N, Munell F, Nevo Y, Péréon Y, Phan H, Sansone VA, Scoto M, Willis T, Finkel RS, Vandenborne K, Cazzaniga S, Montrasio S, Alessi F, Bettica P, Mercuri E, Givinostat Study 51 Investigators, Cooperative International Neuromuscular Research Group (CINRG) Duchenne Natural History Study (DNHS), ImagingDMD Investigators. PMID: 40830818; PMCID: PMC12623843.

View in: PubMed Mentions: 2 Fields:
Neu Neurology
Translation:Humans CTClinical Trials
Hypotonia in the Newborn Infant. Pediatr Clin North Am. 2025 Aug; 72(4):701-745. Laverty CG. PMID: 40619196.

View in: PubMed Mentions: Fields:
Ped Pediatrics
Translation:Humans
Clinical characterization of Collagen XII-related disease caused by biallelic COL12A1 variants. Ann Clin Transl Neurol. 2025 Mar; 12(3):602-614. McCarty RM, Saade D, Munot P, Laverty CG, Pinz H, Zou Y, McAnally M, Yun P, Tian C, Hu Y, Feng L, Phadke R, Ceulemans S, Magoulas P, Skalsky AJ, Friedman JR, Braddock SR, Neuhaus SB, Malicki DM, Bainbridge MN, Nahas S, Dimmock DP, Kingsmore SF, Lotze TE, Foley AR, Muntoni F, Straub V, Donkervoort S, Bönnemann CG. PMID: 39923201; PMCID: PMC11920742.

View in: PubMed Mentions: 1 Fields:
Neu Neurology
Translation:Humans
Assessment of Phosphorodiamidate Morpholino Oligomer Treatment Patterns for Patients with Duchenne Muscular Dystrophy: A MarketScan Claims Analysis. Adv Ther. 2025 Jan; 42(1):523-536. Klimchak AC, Signorovitch J, Innis B, Laverty CG, Gooch K. PMID: 39527337; PMCID: PMC11782370.

View in: PubMed Mentions: 2 Fields:
The Therapeutics
Translation:Humans
Missense variants in CMS22 patients reveal that PREPL has both enzymatic and nonenzymatic functions. JCI Insight. 2024 Sep 10; 9(17). Monnens Y, Theodoropoulou A, Rosier K, Bhalla K, Mahy A, Vanhoutte R, Meulemans S, Cavani E, Antanasijevic A, Lemmens I, Lee JA, Spellicy CJ, Schroer RJ, Maselli RA, Laverty CG, Agostinis P, Pagliarini DJ, Verhelst S, Marcaida MJ, Rochtus A, Dal Peraro M, Creemers JW. PMID: 39078710; PMCID: PMC11385081.

View in: PubMed Mentions: Fields:
Med Medicine (General)
Translation:Humans Cells
Healthcare Stakeholder Perspectives on a Value Assessment Approach for Duchenne Muscular Dystrophy Therapies. J Multidiscip Healthc. 2024; 17:4199-4212. Fischer R, Furlong P, Kennedy A, Maynard K, Penrod M, Miller D, Laverty CG, Lowes LP, Kuntz NL, Shieh PB, Kondejewski J, Neumann PJ, Shafrin J, Willke RJ. PMID: 39224484; PMCID: PMC11368110.

View in: PubMed Mentions: 2
Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol. 2024 Apr; 23(4):393-403. Mercuri E, Vilchez JJ, Boespflug-Tanguy O, Zaidman CM, Mah JK, Goemans N, Müller-Felber W, Niks EH, Schara-Schmidt U, Bertini E, Comi GP, Mathews KD, Servais L, Vandenborne K, Johannsen J, Messina S, Spinty S, McAdam L, Selby K, Byrne B, Laverty CG, Carroll K, Zardi G, Cazzaniga S, Coceani N, Bettica P, McDonald CM, EPIDYS Study Group. PMID: 38508835.

View in: PubMed Mentions: 54 Fields:
Neu Neurology
Translation:Humans CTClinical Trials
Clinical, immunohistochemical, and genetic characterization of splice-altering biallelic DES variants: Therapeutic implications. HGG Adv. 2024 Apr 11; 5(2):100274. Geist Hauserman J, Laverty CG, Donkervoort S, Hu Y, Silverstein S, Neuhaus SB, Saade D, Vaughn G, Malicki D, Kaur R, Li Y, Luo Y, Liu P, Burr P, Foley AR, Mohassel P, Bönnemann CG. PMID: 38358893; PMCID: PMC10876619.

View in: PubMed Mentions: 1 Fields:
Gen Genetics
Translation:Humans Cells
Effectiveness of long-term noninvasive ventilation measured by remote monitoring in neuromuscular disease. ERJ Open Res. 2023 Sep; 9(5). Orr JE, Chen K, Vaida F, Schmickl CN, Laverty CG, Ravits J, Lesser D, Bhattacharjee R, Malhotra A, Owens RL. PMID: 37753280; PMCID: PMC10518857.

View in: PubMed Mentions: 4
BAG3 myofibrillar myopathy presenting with cardiomyopathy. Neuromuscul Disord. 2015 May; 25(5):418-22. Konersman CG, Bordini BJ, Scharer G, Lawlor MW, Zangwill S, Southern JF, Amos L, Geddes GC, Kliegman R, Collins MP. PMID: 25728519.

View in: PubMed Mentions: 32 Fields:
Neu Neurology
Translation:Humans